Pharmaceutical Company PDL BioPharma Files Lawsuit Against Eli Lilly and Company Over Alzheimer’s Treatment Compensation

INDIANAPOLIS, IN — Nevada-based company PDL BioPharma, Inc. has filed a lawsuit against Eli Lilly and Company in the U.S. District Court for the Southern District of Indiana. PDL alleges that Eli Lilly used its technology to develop an Alzheimer’s disease treatment without compensating PDL. According to the lawsuit filed on December 21, 2023, PDL claims that Eli Lilly used its antibody humanization technology to create donanemab, a treatment for Alzheimer’s. Donanemab is expected to receive FDA approval in the first quarter of 2024. The lawsuit refers to a 2000 agreement between Eli Lilly and … Read more